# Source note — ER-100 / partial reprogramming / anti-aging-shot claim

Prepared: 2026-08-10

## Social source
- User supplied: https://www.facebook.com/share/r/1GNcFmExEM/?mibextid=wwXIfr
- Canonical Facebook video: https://www.facebook.com/doctorgabriellelyon/videos/what-if-the-future-of-medicine-is-not-managing-disease-but-reversing-the-biologi/1020623017598691/
- Account/page: Dr. Gabrielle Lyon
- Related Fox News clip: https://www.foxnews.com/video/6398565769112

## Captured caption / metadata excerpt
What if the future of medicine is not managing disease but reversing the biological processes that cause it in the first place?

In my conversation in Fox News, I talked about ER100 which is a new drug and potential gene therapy currently in its first clinical trial with 12 participants. The mechanism is distinct from everything in conventional medicine. Rather than treating symptoms or slowing disease progression, it aims to flip the biological switch at the cellular level, instructing cells to revert to a different functional state. It is a direct intervention at the level of biological aging itself. The trial is early and the sample size is small, but the underlying science represents a fundamental shift in how medicine could approach aging and disease over the coming decades.

If this works, the implications for human health and longevity are unlike anything medicine has produced before. Share this with someone who needs to know this conversation is happening.

## Machine transcript
```text
[0.00 -> 3.72] This ER 100, which is a new drug, gene therapy,
[3.72 -> 6.64] potentially can reverse biological aging.
[6.64 -> 9.32] And typically we think about the treatments of disease
[9.32 -> 10.68] and managing symptoms,
[10.68 -> 13.68] but this essentially flips the biological switch.
[13.68 -> 15.24] It tells the cells actually go back
[15.24 -> 16.36] and do something different.
[16.36 -> 18.56] Right now we're in the first clinical trial
[18.56 -> 19.96] and there's 12 people.
[19.96 -> 22.28] So I believe that it's gonna take some time.
[22.28 -> 24.12] However, if this works,
[24.12 -> 27.44] it is gonna transform human history and lives.
```

## Evidence label
- **Verified clinical-stage fact:** ER-100 is in a Phase 1 clinical trial for optic neuropathies; ClinicalTrials.gov identifies NCT07290244 as a safety/tolerability trial in adults with open-angle glaucoma or non-arteritic anterior ischemic optic neuropathy.
- **Mechanism:** Life Biosciences describes ER-100 as AAV2-OSK / partial epigenetic reprogramming using OCT4, SOX2 and KLF4.
- **Company/regulatory milestone:** Life Biosciences announced FDA IND clearance and later first participant dosed.
- **Not proven:** ER-100 is not an approved anti-aging shot, not proven whole-body age reversal, and not proven human longevity extension.

## Sources checked
- Facebook Reel source: https://www.facebook.com/doctorgabriellelyon/videos/what-if-the-future-of-medicine-is-not-managing-disease-but-reversing-the-biologi/1020623017598691/
- Fox News clip — Dr. Gabrielle Lyon anti-aging shot: https://www.foxnews.com/video/6398565769112
- Life Biosciences — first patient dosed in Phase 1 ER-100 trial: https://www.lifebiosciences.com/life-biosciences-announces-first-patient-dosed-in-phase-1-trial-of-er-100-for-optic-neuropathies/
- Life Biosciences — FDA IND clearance for ER-100: https://www.lifebiosciences.com/life-biosciences-announces-fda-clearance-of-ind-application-for-er-100-in-optic-neuropathies/
- Life Biosciences — Optic Neuropathies and ER-100: https://www.lifebiosciences.com/optic-neuropathies-er-100/
- ClinicalTrials.gov — NCT07290244 ER-100 safety/tolerability trial: https://clinicaltrials.gov/study/NCT07290244
- Nature Biotechnology — FDA go-ahead to test cellular rejuvenation therapy in humans: https://www.nature.com/articles/s41587-026-03037-z
- Managing Expectations — broader Yamanaka / partial-reprogramming source-card: https://managingexpectations.net/blog/articles/yamanaka-factors-partial-reprogramming-longevity-source-card.html
- Managing Expectations — AI/longevity escape velocity source-card: https://managingexpectations.net/blog/articles/ai-longevity-escape-velocity-derya-unutmaz-source-card.html